The General Pharmaceutical Council (GPhC) may look at overprescribing by independent prescriber (IP) pharmacy contractors “in the future”, its deputy regional director David Clark said during a panel at the Pharmacy Show on Sunday (October 15).
Free to registered users
Register to gain full access to C+D and C+D Community content
Already registered?